Mahzi Therapeutics

Mahzi Therapeutics, founded in 2020 and headquartered in San Mateo, California, is a healthcare and biotechnology company dedicated to addressing under-served rare genetic neurodevelopmental disorders. The company's core mission is to develop innovative treatments that significantly improve the quality of life for patients with these conditions. Mahzi Therapeutics focuses on leveraging cutting-edge biotechnological advancements to create a robust pipeline of therapeutic solutions aimed at filling the gaps in current medical offerings.

The company boasts a team of experienced professionals and a board of directors with deep expertise in biotechnology and healthcare. Mahzi Therapeutics has attracted notable investors who share its vision of transforming the landscape of rare genetic disorder treatment. Among its key achievements, the company has made significant strides in its research and development pipeline, positioning itself as a promising player in the biotech industry. Through its focused efforts, Mahzi Therapeutics aims to make a profound impact on the lives of patients and their families affected by rare neurodevelopmental disorders.